Pioneering Biopharmaceutical Research in India

The Nanomedicine Research Group, or NRG is a group of dedicated individuals at the Institute of Chemical Technology, Mumbai, led by Dr. Ratnesh Jain and Dr. Prajakta Dandekar Jain. Our research broadly focuses on biopharmaceutical characterization and in-vitro model development. Our PhD scholars and research scientists have a strong background in areas such as

  • Biopharmaceutical Research
  • In-vitro model development
  • Biophysics and nanofluidics
  • NMR spectroscopy
  • Nanotechnology

50

PhD students

105

Publications and Patents

25

Awards

Research Areas

img

Biological drugs and Biosimilars

Biological drugs are cells or products of cells such as nucleic acids, proteins, hormones and even cells themselves that have therapeutic properties.

img

Developing in-vitro Models

3D cell culture and organs-on-chip technology provide a better representation of in-vivo micro-environment while also reducing the need of animal testing in research

img

3D Printing of Pharmaceuticals

At NRG, researchers are harnessing 3D printing technology to manufacture drugs that are tailor-made, at a small scale for people with rare diseases or specialized needs.

img

Nanotechnology in Medicine

Researchers at the NRG are developing bandages to assist wound healing made of biopolymeric compounds that are converted to nanofibers through a process known as electrospinning.

img

Exploring the power of probiotics

'Researchers at the NRG are studying the protective and nourishing effects of the extracellular and surface proteins of probiotics

img

Applications of Chitosan

Chitosan is a polysaccharide with numerous applications in the biomedical field. Researchers at the NRG have worked on making Chitosan water-soluble,